Financings Of The Fortnight: IPO Volume Up But Post-Offering Performance Falters
This article was originally published in The Pink Sheet Daily
Executive Summary
Some predict a washout for VC funds, too, but SV Life Sciences gathered a $523 million fund that will back 30-32 health care companies.